Crossmark

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis

Crossref DOI link: https://doi.org/10.15252/emmm.201606261

Published Online: 2017-12-07

Published Print: 2018-02

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Al‐Tamari, Hamza M https://orcid.org/0000-0003-3253-1423
Dabral, Swati

Schmall, Anja

Sarvari, Pouya

Ruppert, Clemens

Paik, Jihye

DePinho, Ronald A

Grimminger, Friedrich

Eickelberg, Oliver

Guenther, Andreas

Seeger, Werner

Savai, Rajkumar

Pullamsetti, Soni S https://orcid.org/0000-0003-0440-8831
Funding

Funding for this research was provided by:

Von-Behring-Röntgen-Stiftung

Rhön-Klinikum

Max-Planck-Gesellschaft
License Information

Version of Record valid from 2017-12-07
More Information

Publication History

Received: 2016-01-29

Accepted: 2017-11-03

Published: 2017-12-07